Other studies, however, have reported no significant difference of serum TGFβ1 levels between breast cancer patients and healthy controls, indicating a need for further examination in larger studies (Sheen-Chen et al, 2001; Ivanovic et al, 2003; Lebrecht et al, 2004). The gene discussed is TGFB1; the disease is breast carcinoma.